4503: Astellas Pharma Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Astellas Pharma Inc.

TYO:4503

SummaryFactSheetFinancial
Price
¥2,177.00
Loss Chance
41.8%
6.52JITTA SCORE
35.38%Under Jitta Line
Jitta Ranking
Pharmaceuticals
1 / 37
Health Care
2 / 182
Japan
?
55 / 3,512
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Kyowa Kirin Co., Ltd.
TYO:4151
6.99
¥2,529.00
7.25%
Takeda Pharmaceutical Company Limited
TYO:4502
4.88
¥4,975.00
62.52%
Chugai Pharmaceutical Co., Ltd.
TYO:4519
7.01
¥7,522.00
119.16%
Ono Pharmaceutical Co., Ltd.
TYO:4528
6.75
¥2,345.50
27.79%
Mochida Pharmaceutical Co., Ltd.
TYO:4534
5.18
¥3,130.00
12.31%
Jitta Factors
Growth Opportunity (60)
Recent Business Performance (87)
Financial Strength (85)
Return to Shareholders (47)
Competitive Advantage (70)
Jitta Signs
Revenue and EarningConsistent Growth in the past 3 years
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Interest Coverage RatioGood
SG&A to SalesDecreasing
Operating MarginInconsistent
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.52
35.38%
4.28
127.03%
4.33
144.21%
Pharmaceuticals
6.99
7.25%
4.88
62.52%
7.01
119.16%
COMPANY DESCRIPTION
Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric adenocarcinoma and esophagogastric junction adenocarcinoma; and PADCEV, a treatment for patients with metastatic urothelial carcinoma. It also provides VEOZAH, a treatment for vasomotor symptoms associated with menopause; IZERVAY, a treatment for age-related macular degeneration with geographic atrophy; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf, an immunosuppressant. It offers its products to oncology, ophthalmology, urology, immunology, and women's health areas. The company was formerly known as Yamanouchi Pharmaceutical Co. Ltd. and changed its name to Astellas Pharma Inc. in April 2005. Astellas Pharma Inc. was founded in 1923 and is headquartered in Chuo, Japan.
www.astellas.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.